Skip to main content
SpringerLink
Log in

Species Differences of Serum Albumins: III. Analysis of Structural Characteristics and Ligand Binding Properties During N-B Transitions

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of this study was to investigate the characteristics of the structural transitions and changes in ligand binding properties of different albumins during the pH-dependent structural transition, often referred to as the N-B transition.

Methods. Structural transitions were evaluated by means of spectrometry, differential scanning calorimetry and chemical modification. In addition, ligand binding properties were investigated using typical site-specific bound drugs (warfarin, phenylbutazone, ibuprofen and diazepam).

Results. Conformational changes, including N-B transition, clearly occurred in albumins from all species used in this study. The conformational stabilities of all the albumins were clearly lost in the weakly alkaline pH range. This was probably the result of the destruction of salt bridges between domain I and domain III in the albumin molecule. In addition, the profiles of the ANS-induced fluorescence were different and could be classified into two patterns, suggesting that hydrophobic pockets in the albumin molecules were different for the different species. The data suggest that the amino acid residues responsible for the transitions were some of the His residues located in domain I. Further, the ligand binding properties of the albumins were slightly different but statistically significant.

Conclusions. The overall mechanisms of the N-B transition may be similar for all the albumins, but its impact is considerably different among the species in terms of both structural characteristics and ligand binding properties. Furthermore, the transitions appear to be multi-step transitions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Part II: T. Kosa, T. Maruyama, and M. Otagiri. Species differences of serum albumins, II. The chemical and thermal stability, Pharm. Res. 15:447–452 (1998).

    Google Scholar 

  2. W. J. J. Leonard, K. K. Vijai, and J. F. Foster. A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies, J. Biol. Chem. 238: 1984–1988 (1963).

    Google Scholar 

  3. R. Weisiger, J. Gollan, and R. Ockner. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances, Science 211:1048–1051 (1981).

    Google Scholar 

  4. E. L. Forker and B. A. Luxon. Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface, J. Clin. Invest., 72:1764–1771 (1983).

    Google Scholar 

  5. E. L. Forker and B. A. Luxon. Albumin helps mediate removal of taurocholate by rat liver, J. Clin. Invest. 67:1517–1522 (1981).

    Google Scholar 

  6. R. K. Ockner, R. A. Weisiger, and J. L. Gollan. Hepatic uptake of albumin-bound substances: albumin receptor concept, Am. J. Physiol. 245:G13–18 (1983).

    Google Scholar 

  7. E. L. Forker and B. A. Luxon. Hepatic uptake of propranolol [letter], Hepatology, 6:340–341 (1986).

    Google Scholar 

  8. B. L. Trigatti and G. E. Gerber. A direct role for serum albumin in the cellular uptake of long-chain fatty acids, Biochem. J. 308:155–159 (1995).

    Google Scholar 

  9. T. Horie, T. Mizuma, S. Kasai, and S. Awazu, Conformational change in plasma albumin due to interaction with isolated rat hepatocyte, Am. J. Physiol. 254:G465–470 (1988).

    Google Scholar 

  10. G. Sudlow, D. J. Birkett, and D. N. Wade. The characterization of two specific drug binding sites on human serum albumin, Mol. Pharmacol. 11:824–832 (1975).

    Google Scholar 

  11. J. H. Droge, L. H. Janssen, and J. Wilting. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry, Biochim. Biophy. Acta 827:396–402 (1985).

    Google Scholar 

  12. O. J. Bos, M. J. Fischer, J. Wilting, and L. H. Janssen. Mechanism by which warfarin binds to human serum albumin. Stoppedflow kinetic experiments with two large fragments of albumin, Biochem. Pharmacol. 38:1979–1984 (1989).

    Google Scholar 

  13. J. Wilting, W. van der Giesen, L. H. Janssen, M. M. Weideman, M. Otagiri, and J. H. Perrin. The effect of albumin conformation on the binding of warfarin to human serum albumin, J. Biol. Chem. 255:3032–3037(1980).

    Google Scholar 

  14. E. L. Vansterkenburg, J. Wilting, and L. H. Janssen. Influence of pH on the binding of suramin to human serum albumin, Biochem. Pharmacol., 38:3029–3035 (1989).

    Google Scholar 

  15. A. A. Elbary, J. J. Vallner, and C. W. Whitworth. Effect of albumin conformation on the binding of phenylbutazone and oxyphenbutazone to human serum albumin, J. Pharm. Sci. 71:241–244 (1982).

    Google Scholar 

  16. B. J. t' Hart, J. Wilting, and J. de Gier. Evidence for distinct consecutive steps in the neutral to base transition of human serum albumin, Biochem. Pharmacol., 35:1005–1009 (1986).

    Google Scholar 

  17. J. Wilting, B. J. t' Hart, and J. de Gier. The role of albumin conformation in the binding of diazepam to human serum albumin, Biochim. Biophy. Acta 626:291–298 (1980).

    Google Scholar 

  18. S. Wanwimolruk, and D. J. Birkett. The effects of N-B transition of human serum albumin on the specific drug-binding sites, Biochim. Biophy. Acta 709:247–255 (1982).

    Google Scholar 

  19. L. H. Janssen, J. H. Droge, F. C. Durlinger, and F. J. Fruytier. The pH dependence of the thermodynamics of the interaction of diazepam with human serum albumin, J. Biol. Chem. 260:11442–11445 (1985).

    Google Scholar 

  20. X. M. He and D. C. Carter. Atomic structure and chemistry of human serum albumin, Nature, 358:209–215 (1992).

    Google Scholar 

  21. J. X. Ho, E. W. Holowachuk, E. J. Norton, P. D. Twigg, and D. C. Carter. X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution, Eur. J. Biochem. 215:205–212 (1993).

    Google Scholar 

  22. T. Kosa, T. Maruyama, and M. Otagiri. Species differences of serum albumins, I. Drug binding sites, Pharm. Res., 14:1608–1613 (1997).

    Google Scholar 

  23. J. F. Labro, and L. H. Janssen. A proton nuclear magnetic resonance study of human serum albumin in the neutral pH region, Biochim. Biophy. Acta 873:267–278 (1986).

    Google Scholar 

  24. J. L. Roosemont. Reaction of histidine residues in proteins with diethylpyrocarbonate: differential molar absorptivities and reactivities, Anal. Biochem. 88:314–320 (1978).

    Google Scholar 

  25. J. H. M. Dröge, J. Wilting, and L. H. M. Janssen. A comparative study of some physicochemical properties of human serum albumin samples from different sources II, The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam. Biochem. Pharmacol. 31:3781–3786 (1982).

    Google Scholar 

  26. R. L. Perlman and H. Edelhoch. The formation of diiodotyrosine in iodinated human serum albumin, J. Biol. Chem. 242:2416–2422 (1967).

    Google Scholar 

  27. E. S. Benson, B. E. Hallaway, and R. W. Lumry. Deuteriumhydrogen exchange analysis of pH-dependent transitions in bovine plasma albumin, J. Biol. Chem. 239:122–129 (1964).

    Google Scholar 

  28. E. S. Benson and B. E. Hallaway. On the mechanisms of pH-dependent hydrogen exchange of bovine plasma albumin in the range of pH 5 to 8.5, J. Biol. Chem. 245:4144–4149 (1970).

    Google Scholar 

  29. O. J. Bos, J. F. Labro, M. J. Fischer, J. Wilting, and L. H. Janssen. The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin, J. Biol. Chem. 264:953–959 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, 862, Japan

    Takamitsu Kosa, Toru Maruyama, Norifumi Sakai, Naoko Yonemura, Shoji Yahara & Masaki Otagiri

  2. Department of Pharmacy, Japanese Red Cross Kumamoto Hospital, 2-2-1 Nagamine-Minami, Kumamoto, 862, Japan

    Toru Maruyama

Authors
  1. Takamitsu Kosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toru Maruyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norifumi Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoko Yonemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoji Yahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaki Otagiri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kosa, T., Maruyama, T., Sakai, N. et al. Species Differences of Serum Albumins: III. Analysis of Structural Characteristics and Ligand Binding Properties During N-B Transitions. Pharm Res 15, 592–598 (1998). https://doi.org/10.1023/A:1011986028529

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011986028529

Search

Navigation